Langerhans cell histiocytosis: Central nervous system involvement treated successfully with 2-chlorodeoxyadenosine

Pediatric Hematology and Oncology

Volumn 18, Issue 3, 2001, Pages 199-203

  Watts, J ^a   Files, B ^a  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Bone marrow suppression; Central nervous system; Chlorodeoxyadenosine; Langerhans cell histiocytosis; Resistant

Indexed keywords

CLADRIBINE;

ADOLESCENT; AMNESIA; ARTICLE; BONE LESION; BONE MARROW SUPPRESSION; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; HEADACHE; HISTIOCYTOSIS X; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; TREATMENT OUTCOME; VOMITING;

EID: 0035088534     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010151114840     Document Type: Article

References (10)

1. Langerhans cell histiocytosis
2. An update on clonality cytokines, and viral etiology in Langerhans cell histiocytosis
3. Lymphohistiocytic disorders
4. The histiocytosis: Clinical presentation and differential diagnosis
5. Nosology and pathology of Langerhans cell histiocytosis
6. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposide and prednisone
7. 2-Chlorodeoxyadenosine to treat refractory histiocytosis X
8. Central nervous system disease in Langerhans cell histiocytosis
9. Report of the histiocyte society workshop on "Central nervous system disease in Langerhans cell histiocytosis"